Drugs

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  

Drugs
Aug 27, 2024, 22:42 | Drugs
Maria Babak: Approval of axatilimab-csfr is a significant development in the treatment of cGVHD
Maria Babak shared a post by The Babak Lab on LinkedIn: "This is a significant…
Aug 23, 2024, 15:59 | Drugs
Aleix Prat: Our recent article on patritumab deruxtecan is on the list of Nature Communications' Editors’ Highlights
Aleix Prat, Head of the Medical Oncology Department at Hospital Clínic Barcelona, shared a post…
Aug 23, 2024, 14:21 | Drugs
Stephen V Liu: How do we select the optimal regimen for EGFR NSCLC?
Stephen V Liu shared on X: "With FLAURA (osimertinib alone), FLAURA2 (osimertinib with chemotherapy), and…
Aug 23, 2024, 06:30 | Drugs
Taha Al-Juhaishi: Treatment of AML in the community setting
Taha Al-Juhaishi, Associate Director of Hematopoietic Stem Cell Transplantation and Cell Therapy at OU Health…
Aug 20, 2024, 14:50 | Drugs
Key takeaways from the FDA approval of dostarlimab-gxly in endometrial cancer - The Babak Lab
The Babak Lab shared on LinkedIn: "FDA Expands Endometrial Cancer Treatment: The FDA has approved…
Aug 18, 2024, 20:28 | Drugs
Deepa Arora: US FDA Guidance on Dose Optimization for Oncology Drugs
Deepa Arora, Chief Executive Officer at Clinexel Life Sciences Private Limited, shared on LinkedIn: “Clinical…
Aug 17, 2024, 12:02 | Drugs
Vincent Rajkumar: Medicare has negotiated lower prices for prescription drugs
Vincent Rajkumar shared a post on X: "Breaking: Medicare for the first time in history,…
Aug 14, 2024, 07:20 | Drugs
Keith W Pratz: Novel risk signature for AML treated with Azacitidine and Venetoclax
Keith W Pratz, Director of Leukemia at the Hospital of University of Pennsylvania, shared on…
Aug 12, 2024, 13:49 | Drugs
SENTRY study - investigating the safety and efficacy of the combination of selinexor plus ruxolitinib in myelofibrosis
Icahn School of Medicine at Mount Sinai shared on X: "The SENTRY study, led by…
Aug 10, 2024, 17:37 | Drugs
Michael Makris: The therapeutic landscape of ITP treatments is expanding rapidly
Michael Makris, Professor of Haemostasis and Thrombosis at University of Sheffield, shared a paper by…
All: 538 Posts: 151 - 160
Special Coverage